1817-73-8 Usage
Description
2-Bromo-4,6-dinitroaniline is a bright yellow powder with chemical properties described as yellow to orange powder.
Uses
Used in Toxicology and Mutagenicity Testing:
2-Bromo-4,6-dinitroaniline is used as a model chemical in the inter-laboratory evaluation of the bioluminescent Salmonella reverse mutation assay. This application is for detecting mutagenicity, which is crucial in toxicology and environmental safety assessments to identify potential hazards and ensure the safety of substances in various industries.
Air & Water Reactions
2-Bromo-4,6-dinitroaniline may be sensitive to exposure to air . Insoluble in water.
Reactivity Profile
A halogenated and nitrated amine. Amines are chemical bases. They neutralize acids to form salts plus water. These acid-base reactions are exothermic. The amount of heat that is evolved per mole of amine in a neutralization is largely independent of the strength of the amine as a base. Amines may be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen is generated by amines in combination with strong reducing agents, such as hydrides.
Fire Hazard
Flash point data for 2-Bromo-4,6-dinitroaniline are not available, but 2-Bromo-4,6-dinitroaniline is probably combustible.
Check Digit Verification of cas no
The CAS Registry Mumber 1817-73-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,8,1 and 7 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1817-73:
(6*1)+(5*8)+(4*1)+(3*7)+(2*7)+(1*3)=88
88 % 10 = 8
So 1817-73-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H4BrN3O4/c7-4-1-3(9(11)12)2-5(6(4)8)10(13)14/h1-2H,8H2
1817-73-8Relevant articles and documents
Kundu,Aiyar
, p. 40,41,42 (1971)
Novel aminopyrimidine EGFR inhibitor
-
Paragraph 0760-0766, (2021/03/24)
The present invention provides a novel aminopyrimidine compound that is a selective inhibitor of the fourth generation EGFR (T790M/C797S mutation), a pharmaceutical composition containing the compound, a useful intermediate for preparing the compound, and
Antibacterial Compounds
-
Paragraph 0445, (2013/10/07)
The present invention provides a compound of the following formula, salts, racemates, diastereomers, enantiomers, esters, carbamates, phosphates, sulfates, deuterated forms and prodrugs thereof. Also provided is the use of these compounds as antibacterials, compositions comprising them and processes for their manufacture.